Allan Lefer

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Anatomy

Living Beings

Disorders

Chemicals & Drugs

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Ikeda Yasuhiko; Young Lindon H; Lefer Allan M
Rosuvastatin, a new HMG-CoA reductase inhibitor, protects ischemic reperfused myocardium in normocholesterolemic rats.
Booth Gregory; Stalker Timothy J; Lefer Allan M; Scalia Rosario
Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo.
Ikeda Yasuhiko; Young Lindon H; Lefer Allan M
Attenuation of neutrophil-mediated myocardial ischemia-reperfusion injury by a calpain inhibitor.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Allan Lefer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2003: Ikeda Yasuhiko; Young Lindon H; Lefer Allan M
Rosuvastatin, a new HMG-CoA reductase inhibitor, protects ischemic reperfused myocardium in normocholesterolemic rats.
Journal of cardiovascular pharmacology 2003;41(4):649-56.
2002: Booth Gregory; Stalker Timothy J; Lefer Allan M; Scalia Rosario
Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo.
Diabetes 2002;51(5):1556-64.
2002: Ikeda Yasuhiko; Young Lindon H; Lefer Allan M
Attenuation of neutrophil-mediated myocardial ischemia-reperfusion injury by a calpain inhibitor.
American journal of physiology. Heart and circulatory physiology 2002;282(4):H1421-6.
2002: Ikeda Yasuhiko; Young Lindon H; Vournakis John N; Lefer Allan M
Vascular effects of poly-N-acetylglucosamine in isolated rat aortic rings.
The Journal of surgical research 2002;102(2):215-20.
2001: Lefer D J; Scalia R; Jones S P; Sharp B R; Hoffmeyer M R; Farvid A R; Gibson M F; Lefer A M
HMG-CoA reductase inhibition protects the diabetic myocardium from ischemia-reperfusion injury.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(8):1454-6.
2001: Stalker T J; Lefer A M; Scalia R
A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid.
British journal of pharmacology 2001;133(3):406-12.
2001: Young L H; Ikeda Y; Lefer A M
Caveolin-1 peptide exerts cardioprotective effects in myocardial ischemia-reperfusion via nitric oxide mechanism.
American journal of physiology. Heart and circulatory physiology 2001;280(6):H2489-95.
2001: Booth G; Stalker T J; Lefer A M; Scalia R
Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin.
American journal of physiology. Endocrinology and metabolism 2001;280(6):E848-56.
2001: Scalia R; Gooszen M E; Jones S P; Hoffmeyer M; Rimmer D M; Trocha S D; Huang P L; Smith M B; Lefer A M; Lefer D J
Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice.
Circulation 2001;103(21):2598-603.
2001: Young L H; Ikeda Y; Lefer A M
Protein kinase inhibition exerts cardioprotective effects in myocardial ischemia/reperfusion via inhibition of superoxide release.
Methods and findings in experimental and clinical pharmacology 2001;23(3):107-14.
2001: Armstead V E; Minchenko A G; Scalla R; Lefer A M
Pulmonary tissue factor mRNA expression during murine traumatic shock: effect of P-selectin blockade.
Shock (Augusta, Ga.) 2001;15(4):323-6.
2001: Lefer A M; Scalia R; Lefer D J
Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.
Cardiovascular research 2001;49(2):281-7.
2001: Ikeda Y; Young L H; Scalia R; Ross C R; Lefer A M
PR-39, a proline/arginine-rich antimicrobial peptide, exerts cardioprotective effects in myocardial ischemia-reperfusion.
Cardiovascular research 2001;49(1):69-77.
2000: Scalia R; Coyle K M; Levine B J; Booth G; Lefer A M
C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2000;14(14):2357-64.
2000: Young L H; Ikeda Y; Scalia R; Lefer A M
C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion.
American journal of physiology. Heart and circulatory physiology 2000;279(4):H1453-9.
2000: Young L H; Ikeda Y; Scalia R; Lefer A M
Wortmannin, a potent antineutrophil agent, exerts cardioprotective effects in myocardial ischemia/reperfusion.
The Journal of pharmacology and experimental therapeutics 2000;295(1):37-43.
2000: Ikeda Y; Young L H; Scalia R; Lefer A M
Cardioprotective effects of citrulline in ischemia/reperfusion injury via a non-nitric oxide-mediated mechanism.
Methods and findings in experimental and clinical pharmacology 2000;22(7):563-71.
2000: Williams K J; Scalia R; Mazany K D; Rodrigueza W V; Lefer A M
Rapid restoration of normal endothelial functions in genetically hyperlipidemic mice by a synthetic mediator of reverse lipid transport.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(4):1033-9.
2000: Campbell B; Chuhran C; Lefer A M
Vascular endothelial growth factor attenuates trauma-induced injury in rats.
British journal of pharmacology 2000;129(1):71-6.
2000: Scalia R; Pruefer D; Lefer A M
A novel lysophosphatidic acid analog, LXR-1035, inhibits leukocyte-endothelium interaction via inhibition of cell adhesion molecules.
Journal of leukocyte biology 2000;67(1):26-33.
1999: Pruefer D; Scalia R; Lefer A M
Homocysteine provokes leukocyte-endothelium interaction by downregulation of nitric oxide.
General pharmacology 1999;33(6):487-98.
1999: Armstead V E; Opentanova I L; Minchenko A G; Lefer A M
Tissue factor expression in vital organs during murine traumatic shock: role of transcription factors AP-1 and NF-kappaB.
Anesthesiology 1999;91(6):1844-52.
1999: Pruefer D; Scalia R; Lefer A M
Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(12):2894-900.
1999: Lefer A M
Role of the beta2-integrins and immunoglobulin superfamily members in myocardial ischemia-reperfusion.
The Annals of thoracic surgery 1999;68(5):1920-3.
1999: Campbell B; Chuhran C M; Lefer D J; Lefer A M
Cardioprotective effects of abciximab (ReoPro) in an isolated perfused rat heart model of ischemia and reperfusion.
Methods and findings in experimental and clinical pharmacology 1999;21(8):529-34.
1999: Hayward R; Lefer A M
Acute mesenteric ischemia and reperfusion: protective effects of recombinant soluble P-selectin glycoprotein ligand-1.
Shock (Augusta, Ga.) 1999;12(3):201-7.
1999: Hayward R; Lefer A M
Administration of polymerized bovine hemoglobin improves survival in a rat model of traumatic shock.
Methods and findings in experimental and clinical pharmacology 1999;21(6):427-33.
1999: Lefer A M; Campbell B; Shin Y K; Scalia R; Hayward R; Lefer D J
Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts.
Circulation 1999;100(2):178-84.
1999: Scalia R; Armstead V E; Minchenko A G; Lefer A M
Essential role of P-selectin in the initiation of the inflammatory response induced by hemorrhage and reinfusion.
The Journal of experimental medicine 1999;189(6):931-8.
1999: Lefer A M; Lefer D J
Nitric oxide. II. Nitric oxide protects in intestinal inflammation.
The American journal of physiology 1999;276(3 Pt 1):G572-5.
1999: Campbell B; Adams J; Shin Y K; Lefer A M
Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart.
Journal of molecular and cellular cardiology 1999;31(2):467-76.
1999: Hayward R; Campbell B; Shin Y K; Scalia R; Lefer A M
Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats.
Cardiovascular research 1999;41(1):65-76.
1999: Scalia R; Hayward R; Armstead V E; Minchenko A G; Lefer A M
Effect of recombinant soluble P-selectin glycoprotein ligand-1 on leukocyte-endothelium interaction in vivo. Role in rat traumatic shock.
Circulation research 1999;84(1):93-102.
1999: Minchenko A G; Armstead V E; Opentanova I L; Lefer A M
Endothelin-1, endothelin receptors and ecNOS gene transcription in vital organs during traumatic shock in rats.
Endothelium : journal of endothelial cell research 1999;6(4):303-14.
1998: Lefer A M; Campbell B; Shin Y K
Effects of a metalloproteinase that truncates P-selectin glycoprotein ligand on neutrophil-induced cardiac dysfunction in ischemia/reperfusion.
Journal of molecular and cellular cardiology 1998;30(12):2561-6.
1998: Hayward R; Lefer A M
Time course of endothelial-neutrophil interaction in splanchnic artery ischemia-reperfusion.
The American journal of physiology 1998;275(6 Pt 2):H2080-6.
1998: Lefer A M; Campbell B; Scalia R; Lefer D J
Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins.
Circulation 1998;98(13):1322-8.
1998: Campbell B; Shin Y K; Scalia R; Lefer A M
Beneficial effects of N,N,N-trimethylsphingosine following ischemia and reperfusion in the isolated perfused rat heart.
Cardiovascular research 1998;39(2):393-400.
1998: Bains A S; Scalia R; Lefer A M
Effects of LEX032, a novel recombinant serine protease inhibitor, on N(G)-nitro-L-arginine methyl ester induced leukocyte-endothelial cell interactions.
European journal of pharmacology 1998;356(1):67-72.
1998: Scalia R; Lefer A M
In vivo regulation of PECAM-1 activity during acute endothelial dysfunction in the rat mesenteric microvasculature.
Journal of leukocyte biology 1998;64(2):163-9.
1998: Nossuli T O; Hayward R; Jensen D; Scalia R; Lefer A M
Mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury.
The American journal of physiology 1998;275(2 Pt 2):H509-19.
1998: Shin Y K; Campbell B; Lefer A M
Novel beneficial effects of defibrotide, an endothelium protecting agent, following ischemia and reperfusion in the isolated perfused rat heart.
Methods and findings in experimental and clinical pharmacology 1998;20(6):463-71.
1998: Hayward R; Scalia R; Hopper B; Appel J Z; Lefer A M
Cellular mechanisms of heparinase III protection in rat traumatic shock.
The American journal of physiology 1998;275(1 Pt 2):H23-30.
1998: Scalia R; Appel J Z; Lefer A M
Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: role of P-selectin, ICAM-1, and VCAM-1.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(7):1093-100.
1998: Hayward R; Lefer A M
L-arginine attenuates endothelial dysfunction and prolongs survival in rats subjected to traumatic shock.
Endothelium : journal of endothelial cell research 1998;6(1):71-9.
1997: Armstead V E; Minchenko A G; Campbell B; Lefer A M
P-selectin is up-regulated in vital organs during murine traumatic shock.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1997;11(14):1271-9.
1997: Hayward R; Nossuli T O; Lefer A M
Heparinase III exerts endothelial and cardioprotective effects in feline myocardial ischemia-reperfusion injury.
The Journal of pharmacology and experimental therapeutics 1997;283(3):1032-8.
1997: Nossuli T O; Hayward R; Scalia R; Lefer A M
Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats.
Circulation 1997;96(7):2317-24.
1997: Kochilas L; Campbell B; Scalia R; Lefer A M
Beneficial effects of C1 esterase inhibitor in murine traumatic shock.
Shock (Augusta, Ga.) 1997;8(3):165-9.
1997: Hayward R; Nossuli T O; Scalia R; Lefer A M
Cardioprotective effect of interleukin-10 in murine myocardial ischemia-reperfusion.
European journal of pharmacology 1997;334(2-3):157-63.
1997: Scalia R; Gefen J; Petasis N A; Serhan C N; Lefer A M
Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(18):9967-72.
1997: Armstead V E; Minchenko A G; Schuhl R A; Hayward R; Nossuli T O; Lefer A M
Regulation of P-selectin expression in human endothelial cells by nitric oxide.
The American journal of physiology 1997;273(2 Pt 2):H740-6.
1997: Scalia R; Murohara T; Campbell B; Kaji A; Lefer A M
Lysophosphatidylcholine stimulates leukocyte rolling and adherence in rat mesenteric microvasculature.
The American journal of physiology 1997;272(6 Pt 2):H2584-90.
1997: Lefer D J; Scalia R; Campbell B; Nossuli T; Hayward R; Salamon M; Grayson J; Lefer A M
Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats.
The Journal of clinical investigation 1997;99(4):684-91.
1996: Scalia R; Kochilas L; Campbell B; Lefer A M
Effects of defibrotide on leukocyte-endothelial cell interaction in the rat mesenteric vascular bed: role of P-selectin.
Methods and findings in experimental and clinical pharmacology 1996;18(10):669-76.
1996: Delyani J A; Nossuli T O; Scalia R; Thomas G; Garvey D S; Lefer A M
S-nitrosylated tissue-type plasminogen activator protects against myocardial ischemia/reperfusion injury in cats: role of the endothelium.
The Journal of pharmacology and experimental therapeutics 1996;279(3):1174-80.
1996: Murohara T; Lefer A M
Autocrine effects of endothelin-1 on leukocyte-endothelial interaction: stimulation of endothelin B receptor subtype reduces endothelial adhesiveness via a nitric oxide-dependent mechanism.
Blood 1996;88(10):3894-900.
1996: Lefer A M; Lefer D J
The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion.
Cardiovascular research 1996;32(4):743-51.
1996: Scalia R; Pearlman S; Campbell B; Lefer A M
Time course of endothelial dysfunction and neutrophil adherence and infiltration during murine traumatic shock.
Shock (Augusta, Ga.) 1996;6(3):177-82.
1996: Guo J P; Murohara T; Buerke M; Scalia R; Lefer A M
Direct measurement of nitric oxide release from vascular endothelial cells.
Journal of applied physiology (Bethesda, Md. : 1985) 1996;81(2):774-9.
1996: Delyani J A; Murohara T; Nossuli T O; Lefer A M
Protection from myocardial reperfusion injury by acute administration of 17 beta-estradiol.
Journal of molecular and cellular cardiology 1996;28(5):1001-8.
1996: Murohara T; Scalia R; Lefer A M
Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors.
Circulation research 1996;78(5):780-9.
1996: Murohara T; Delyani J A; Albelda S M; Lefer A M
Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(9):3550-7.
1996: Ryan S V; Carrithers S L; Parkinson S J; Skurk C; Nuss C; Pooler P M; Owen C S; Lefer A M; Waldman S A
Hypotensive mechanisms of amifostine.
Journal of clinical pharmacology 1996;36(4):365-73.
1996: Murohara T; Buerke M; Lefer A M
Cardioprotective actions of oligotide, a single stranded polydeoxyribonucleotide complex, in myocardial ischaemia and reperfusion injury.
British journal of pharmacology 1996;117(6):1000-8.
1996: Delyani J A; Murohara T; Lefer A M
Novel recombinant serpin, LEX-032, attenuates myocardial reperfusion injury in cats.
The American journal of physiology 1996;270(3 Pt 2):H881-7.
1996: Scalia R; Murohara T; Delyani J A; Nossuli T O; Lefer A M
Myocardial protection by N,N,N-trimethylsphingosine in ischemia reperfusion injury is mediated by inhibition of P-selectin.
Journal of leukocyte biology 1996;59(3):317-24.
1996: Scalia R; Gauthier T W; Murohara T; Lefer A M
Oligotide attenuates leukocyte-endothelial cell interaction via P-selectin in the rat mesenteric vascular bed.
European journal of pharmacology 1996;296(2):181-7.
1995: Murohara T; Margiotta J; Phillips L M; Paulson J C; DeFrees S; Zalipsky S; Guo L S; Lefer A M
Cardioprotection by liposome-conjugated sialyl Lewisx-oligosaccharide in myocardial ischaemia and reperfusion injury.
Cardiovascular research 1995;30(6):965-74.
1995: Murohara T; Parkinson S J; Waldman S A; Lefer A M
Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets. Role of protein kinase C.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(11):2068-75.
1995: Murohara T; Guo J P; Delyani J A; Lefer A M
Cardioprotective effects of selective inhibition of the two complement activation pathways in myocardial ischemia and reperfusion injury.
Methods and findings in experimental and clinical pharmacology 1995;17(8):499-507.
1995: Scalia R; Gauthier T W; Lefer A M
Beneficial effects of LEX032, a novel recombinant serine protease inhibitor, in murine traumatic shock.
Shock (Augusta, Ga.) 1995;4(4):251-6.
1995: Gauthier T W; Scalia R; Murohara T; Guo J P; Lefer A M
Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(10):1652-9.
1995: Lefer A M
Attenuation of myocardial ischemia-reperfusion injury with nitric oxide replacement therapy.
The Annals of thoracic surgery 1995;60(3):847-51.
1995: Guo J P; Panday M M; Consigny P M; Lefer A M
Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury.
The American journal of physiology 1995;269(3 Pt 2):H1122-31.
1995: Murohara T; Guo J P; Lefer A M
Cardioprotection by a novel recombinant serine protease inhibitor in myocardial ischemia and reperfusion injury.
The Journal of pharmacology and experimental therapeutics 1995;274(3):1246-53.
1995: Lefer A M
Role of selectins in myocardial ischemia-reperfusion injury.
The Annals of thoracic surgery 1995;60(3):773-7.
1995: Buerke M; Murohara T; Skurk C; Nuss C; Tomaselli K; Lefer A M
Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(17):8031-5.
1995: Murohara T; Buerke M; Margiotta J; Ruan F; Igarashi Y; Hakomori S; Lefer A M
Myocardial and endothelial protection by TMS in ischemia-reperfusion injury.
The American journal of physiology 1995;269(2 Pt 2):H504-14.
1995: Lefer A M; Murohara T
Comparative pharmacology of nitric oxide and nitric oxide generators on cardiac contractility in mammalian species.
International journal of cardiology 1995;50(3):239-42.
1995: Buerke M; Murohara T; Lefer A M
Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion.
Circulation 1995;91(2):393-402.
1995: Skurk C; Nuss C; Lefer A M
Beneficial effects of oligotide, a novel oligodeoxyribonucleotide, in murine traumatic shock.
Shock (Augusta, Ga.) 1995;3(1):13-20.
1995: Weyrich A S; Buerke M; Albertine K H; Lefer A M
Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium.
Journal of leukocyte biology 1995;57(1):45-55.
1994: Skurk C; Buerke M; Guo J P; Paulson J; Lefer A M
Sialyl Lewisx-containing oligosaccharide exerts beneficial effects in murine traumatic shock.
The American journal of physiology 1994;267(6 Pt 2):H2124-31.
1994: Lefer A M; Murohara T; Buerke M
Effects of taprostene on neutrophil-endothelial interactions in isolated coronary arteries.
Methods and findings in experimental and clinical pharmacology 1994;16(9):623-31.
1994: Weyrich A S; Ma X L; Buerke M; Murohara T; Armstead V E; Lefer A M; Nicolas J M; Thomas A P; Lefer D J; Vinten-Johansen J
Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle.
Circulation research 1994;75(4):692-700.
1994: Buerke M; Weyrich A S; Murohara T; Queen C; Klingbeil C K; Co M S; Lefer A M
Humanized monoclonal antibody DREG-200 directed against I-selectin protects in feline myocardial reperfusion injury.
The Journal of pharmacology and experimental therapeutics 1994;271(1):134-42.
1994: Gauthier T W; Davenpeck K L; Lefer A M
Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion.
The American journal of physiology 1994;267(4 Pt 1):G562-8.
1994: Davenpeck K L; Gauthier T W; Lefer A M
Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation.
Gastroenterology 1994;107(4):1050-8.
1994: Murohara T; Buerke M; Lefer A M
Polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction. Role of selectins.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(9):1509-19.
1994: Davenpeck K L; Gauthier T W; Albertine K H; Lefer A M
Role of P-selectin in microvascular leukocyte-endothelial interaction in splanchnic ischemia-reperfusion.
The American journal of physiology 1994;267(2 Pt 2):H622-30.
1994: Guo J P; Milhoan K A; Tuan R S; Lefer A M
Beneficial effect of SPM-5185, a cysteine-containing nitric oxide donor, in rat carotid artery intimal injury.
Circulation research 1994;75(1):77-84.
1994: Mead P S; Guo J P; Lefer A M; Pierce S; Palladino M
Protective effects of a monoclonal antibody against lipid A in endotoxic shock.
Methods and findings in experimental and clinical pharmacology 1994;16(6):405-12.
1994: Guo J P; Siegfried M R; Lefer A M
Endothelial preserving actions of a nitric oxide donor in carotid arterial intimal injury.
Methods and findings in experimental and clinical pharmacology 1994;16(5):347-54.
1994: Albertine K H; Weyrich A S; Ma X L; Lefer D J; Becker L C; Lefer A M
Quantification of neutrophil migration following myocardial ischemia and reperfusion in cats and dogs.
Journal of leukocyte biology 1994;55(5):557-66.
1994: Christopher T A; Ma X L; Gauthier T W; Lefer A M
Beneficial actions of CP-0127, a novel bradykinin receptor antagonist, in murine traumatic shock.
The American journal of physiology 1994;266(3 Pt 2):H867-73.
1994: Buerke M; Weyrich A S; Zheng Z; Gaeta F C; Forrest M J; Lefer A M
Sialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats.
The Journal of clinical investigation 1994;93(3):1140-8.
1994: Lefer A M; Weyrich A S; Buerke M
Role of selectins, a new family of adhesion molecules, in ischaemia-reperfusion injury.
Cardiovascular research 1994;28(3):289-94.
1994: Buerke M; Weyrich A S; Lefer A M
Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil-released mediators.
The American journal of physiology 1994;266(1 Pt 2):H128-36.
1994: Christopher T A; Ma X L; Lefer A M
Beneficial actions of S-nitroso-N-acetylpenicillamine, a nitric oxide donor, in murine traumatic shock.
Shock (Augusta, Ga.) 1994;1(1):19-24.
1994: Lefer A M; Ma X L
PMN adherence to cat ischemic-reperfused mesenteric vascular endothelium under flow: role of P-selectin.
Journal of applied physiology (Bethesda, Md. : 1985) 1994;76(1):33-8.
1993: Ma X L; Weyrich A S; Lefer D J; Buerke M; Albertine K H; Kishimoto T K; Lefer A M
Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium.
Circulation 1993;88(2):649-58.
1993: Weyrich A S; Ma X Y; Lefer D J; Albertine K H; Lefer A M
In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury.
The Journal of clinical investigation 1993;91(6):2620-9.
1993: Lefer A M; Ma X L
Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(6):771-6.
1993: Davenpeck K L; Guo J P; Lefer A M
Pulmonary artery endothelial dysfunction following ischemia and reperfusion of the rabbit lung.
Journal of vascular research 1993;30(3):145-53.
1993: Lefer A M; Ma X L
Cytokines and growth factors in endothelial dysfunction.
Critical care medicine 1993;21(2 Suppl):S9-14.
1993: Ma X L; Weyrich A S; Lefer D J; Lefer A M
Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium.
Circulation research 1993;72(2):403-12.
1993: Lefer A M; Ma X L; Weyrich A S; Scalia R
Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(3):1018-22.
1993: Lefer A M; Lefer D J
Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock.
Annual review of pharmacology and toxicology 1993;33():71-90.
1993: Lefer A M; Ma X L; Weyrich A; Lefer D J
Endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury.
Agents and actions. Supplements 1993;41():127-35.
1993: Lefer A M; Siegfried M R; Ma X L
Protection of ischemia-reperfusion injury by sydnonimine NO donors via inhibition of neutrophil-endothelium interaction.
Journal of cardiovascular pharmacology 1993;22 Suppl 7():S27-33.
1992: Symington P A; Ma X L; Lefer A M
Protective actions of S-nitroso-N-acetylpenicillamine (SNAP) in a rat model of hemorrhagic shock.
Methods and findings in experimental and clinical pharmacology 1992;14(10):789-97.
1992: Carey C; Siegfried M R; Ma X L; Weyrich A S; Lefer A M
Antishock and endothelial protective actions of a NO donor in mesenteric ischemia and reperfusion.
Circulatory shock 1992;38(3):209-16.
1992: Siegfried M R; Carey C; Ma X L; Lefer A M
Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion.
The American journal of physiology 1992;263(3 Pt 2):H771-7.
1992: Ma X L; Lefer D J; Lefer A M; Rothlein R
Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion.
Circulation 1992;86(3):937-46.
1992: Weyrich A S; Ma X L; Lefer A M
The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat.
Circulation 1992;86(1):279-88.
1992: Tsao P S; Ma X L; Lefer A M
Activated neutrophils aggravate endothelial dysfunction after reperfusion of the ischemic feline myocardium.
American heart journal 1992;123(6):1464-71.
1992: Lefer A M; Tsao P S; Ma X L; Sampath T K
Anti-ischaemic and endothelial protective actions of recombinant human osteogenic protein (hOP-1).
Journal of molecular and cellular cardiology 1992;24(6):585-93.
1992: Ma X L; Weyrich A S; Krantz S; Lefer A M
Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusion.
The Journal of pharmacology and experimental therapeutics 1992;260(3):1229-36.
1992: Siegfried M R; Ma X L; Lefer A M
Splanchnic vascular endothelial dysfunction in rat endotoxemia: role of superoxide radicals.
European journal of pharmacology 1992;212(2-3):171-6.
1992: Siegfried M R; Erhardt J; Rider T; Ma X L; Lefer A M
Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion.
The Journal of pharmacology and experimental therapeutics 1992;260(2):668-75.
1992: Karasawa A; Rochester J A; Lefer A M
Effects of adenosine, an adenosine-A1 antagonist, and their combination in splanchnic occlusion shock in rats.
Circulatory shock 1992;36(2):154-61.
1992: Ma X L; Johnson G; Lefer A M
Low doses of superoxide dismutase and a stable prostacyclin analogue protect in myocardial ischemia and reperfusion.
Journal of the American College of Cardiology 1992;19(1):197-204.
1992: Lefer A M; Ma X L
Role of leukotriene B4 in neutrophil-endothelium interactions.
Agents and actions. Supplements 1992;37():1-9.
1991: Ma X L; Porta R; Pescador R; Lefer A M
Novel beneficial mechanisms of defibrotide, a prostacyclin enhancing agent in splanchnic artery occlusion and reperfusion in rats.
Methods and findings in experimental and clinical pharmacology 1991;13(10):667-74.
1991: Ma X L; Tsao P S; Lefer A M
Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion.
The Journal of clinical investigation 1991;88(4):1237-43.
1991: Lefer A M
Mechanisms of the protective effects of transforming growth factor-beta in reperfusion injury.
Biochemical pharmacology 1991;42(7):1323-7.
1991: Lefer A M; Tsao P S; Ma X L
Shock- and ischemia-induced mechanisms of impairment of endothelium-mediated vasodilation.
Chest 1991;100(3 Suppl):160S-163S.
1991: Viehman G E; Ma X L; Lefer D J; Lefer A M
Time course of endothelial dysfunction and myocardial injury during coronary arterial occlusion.
The American journal of physiology 1991;261(3 Pt 2):H874-81.
1991: Karasawa A; Guo J P; Ma X L; Tsao P S; Lefer A M
Protective actions of a leukotriene B4 antagonist in splanchnic ischemia and reperfusion in rats.
The American journal of physiology 1991;261(2 Pt 1):G191-8.
1991: Ma X L; Tsao P S; Viehman G E; Lefer A M
Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfused cat coronary artery.
Circulation research 1991;69(1):95-106.
1991: Karasawa A; Guo J P; Ma X L; Lefer A M
Beneficial effects of transforming growth factor-beta and tissue plasminogen activator in splanchnic artery occlusion and reperfusion in cats.
Journal of cardiovascular pharmacology 1991;18(1):95-105.
1991: Ma X L; Johnson G; Lefer A M
Mechanisms of inhibition of nitric oxide production in a murine model of splanchnic artery occlusion shock.
Archives internationales de pharmacodynamie et de thérapie 1991;311():89-103.
1991: Lefer A M; Johnson G; Ma X L; Tsao P S; Thomas G R
Cardioprotective and endothelial protective effects of [Ala-IL8]77 in a rabbit model of myocardial ischaemia and reperfusion.
British journal of pharmacology 1991;103(1):1153-9.
1991: Lefer A M; Tsao P S; Lefer D J; Ma X L
Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1991;5(7):2029-34.
1991: Karasawa A; Rochester J A; Ma X L; Lefer A M
Protection of endothelial damage and systemic shock by benidipine, a calcium antagonist, in rats subjected to splanchnic ischemia and reperfusion.
Circulatory shock 1991;33(3):135-41.
1991: Ma X L; Karasawa A; Lefer A M
Mechanism of the protective action of Bay-u-3405, a new specific thromboxane receptor antagonist, in arachidonate-induced sudden death.
Methods and findings in experimental and clinical pharmacology 1991;13(2):105-10.
1991: Johnson G; Tsao P S; Lefer A M
Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion.
Critical care medicine 1991;19(2):244-52.
1991: Lefer A M; Lefer D J
Endothelial dysfunction in myocardial ischemia and reperfusion: role of oxygen-derived free radicals.
Basic research in cardiology 1991;86 Suppl 2():109-16.
1990: Tsao P S; Lefer A M
Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts.
The American journal of physiology 1990;259(6 Pt 2):H1660-6.
1990: Viehman G E; Ma X L; Lefer A M
Daltroban, a thromboxane receptor antagonist, protects the myocardium against reperfusion injury following myocardial ischemia without protecting the coronary endothelium.
Methods and findings in experimental and clinical pharmacology 1990;12(10):651-6.
1990: Tsao P S; Lefer A M
Cardioprotective actions of the specific thromboxane receptor antagonist (+)-S145Na following coronary occlusion and reperfusion in the rat.
Research communications in chemical pathology and pharmacology 1990;70(2):205-11.
1990: Tsao P S; Aoki N; Lefer D J; Johnson G; Lefer A M
Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat.
Circulation 1990;82(4):1402-12.
1990: Lefer A M; Tsao P; Aoki N; Palladino M A
Mediation of cardioprotection by transforming growth factor-beta.
Science (New York, N.Y.) 1990;249(4964):61-4.
1990: Karasawa A; Taylor P A; Lefer A M
Protective effects of KW-3635, a novel thromboxane A2 antagonist, in murine traumatic shock.
European journal of pharmacology 1990;182(1):1-8.
1990: Lefer A M
Prostacyclin, high density lipoproteins, and myocardial ischemia.
Circulation 1990;81(6):2013-5.
1990: Karasawa A; Rochester J A; Lefer A M
Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock.
Methods and findings in experimental and clinical pharmacology 1990;12(4):231-7.
1990: Johnson G; Furlan L E; Aoki N; Lefer A M
Endothelium and myocardial protecting actions of taprostene, a stable prostacyclin analogue, after acute myocardial ischemia and reperfusion in cats.
Circulation research 1990;66(5):1362-70.
1990: Furlan L E; Johnson G; Siegfried M; Lefer A M
Protective effects of the specific thromboxane receptor antagonist (+)-S145Na in splanchnic artery occlusion shock in rats.
The Journal of pharmacology and experimental therapeutics 1990;253(2):525-9.
1990: Lefer A M; Aoki N; Mulloy D
Coronary endothelium-protective effects of defibrotide in ischaemia and reperfusion.
Naunyn-Schmiedeberg's archives of pharmacology 1990;341(3):246-50.
1990: Johnson G; Tsao P; Lefer A M
Synergism between superoxide dismutase and sodium nitrite in cardioprotection following ischemia and reperfusion.
American heart journal 1990;119(3 Pt 1):530-7.
1990: Johnson G; Lefer A M
Protective effects of a novel 21-aminosteroid during splanchnic artery occlusion shock.
Circulatory shock 1990;30(2):155-64.
1990: Aoki N; Johnson G; Lefer A M
Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock.
The American journal of physiology 1990;258(2 Pt 1):G275-81.
1990: Aoki N; Lefer A M
Protective effects of a novel nonglucocorticoid 21-aminosteroid (U74006F) during traumatic shock in rats.
Journal of cardiovascular pharmacology 1990;15(2):205-10.
1990: Johnson G; Tsao P S; Mulloy D; Lefer A M
Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion.
The Journal of pharmacology and experimental therapeutics 1990;252(1):35-41.
1990: Siegfried M R; Aoki N; Lefer A M; Elisseou E M; Zipkin R E
Direct cardiovascular actions of two metabolites of linoleic acid.
Life sciences 1990;46(6):427-33.
1990: Siegfried M R; Aoki N; Mulloy D; Lefer A M
Direct positive inotropic and vasoconstrictor effects of endothelin.
Heart and vessels 1990;5(3):146-51.
1989: Aoki N; Siegfried M; Tsao P; Lefer A M
Acute effects of unsaturated fatty acids in splanchnic artery occlusion shock.
Prostaglandins, leukotrienes, and essential fatty acids 1989;37(2):89-95.
1989: Lefer A M
Pharmacological modulation of myocardial depressant factor as a mediator of circulatory shock.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):469-72.
1989: Lento P H; Saukkonen K; Aoki N; Lefer A M; Slivjak M J; Smith E F
Beneficial effects of a specific leukotriene receptor antagonist in splanchnic artery occlusion shock.
European journal of pharmacology 1989;165(2-3):241-9.
1989: Aoki N; Siegfried M; Lefer A M
Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries.
The American journal of physiology 1989;256(5 Pt 2):H1509-12.
1989: Tsao P S; Stahl G A; Lefer A M; Salvino J; Pietranico S; Nicolaou K C
Platelet-activating factor (PAF) antagonistic actions of two new analogs of tetrahydrofurans.
Journal of lipid mediators 1989;1(3):189-99.
1989: Bhat A M; Sacks H; Osborne J A; Lefer A M
Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats.
American heart journal 1989;117(4):799-803.
1989: Lefer A M
Induction of tissue injury and altered cardiovascular performance by platelet-activating factor: relevance to multiple systems organ failure.
Critical care clinics 1989;5(2):331-52.
1989: Stahl G L; Tsao P; Lefer A M; Ramphal J Y; Nicolaou K C
Pharmacologic profile of lipoxins A5 and B5: new biologically active eicosanoids.
European journal of pharmacology 1989;163(1):55-60.
1989: Osborne J A; Siegman M J; Sedar A W; Mooers S U; Lefer A M
Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits.
The American journal of physiology 1989;256(3 Pt 1):C591-7.
1989: Osborne J A; Lento P H; Siegfried M R; Stahl G L; Fusman B; Lefer A M
Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment.
The Journal of clinical investigation 1989;83(2):465-73.
1989: Stahl G L; Bitterman H; Lefer A M
Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shock.
Thrombosis research 1989;53(3):327-38.
1989: Lefer A M
Significance of lipid mediators in shock states.
Circulatory shock 1989;27(1):3-12.
1989: Lefer D J; Osborne J A; Lefer A M
Vascular responsiveness of constant flow perfused arteries with intact endothelium.
Methods and findings in experimental and clinical pharmacology 1989;11(1):5-10.
1989: Lefer A M
Platelet activating factor (PAF) and its role in cardiac injury.
Progress in clinical and biological research 1989;301():53-60.
1989: Liao P; Johnson G; Siegfried M; Lefer A M
Protective actions of a new potent thromboxane receptor antagonist in arachidonate induced sudden death.
Eicosanoids 1989;2(1):33-7.
1989: Aoki N; Johnson G; Siegfried M R; Lefer A M
Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock.
Eicosanoids 1989;2(3):169-74.
1989: Lefer A M
Role of thromboxane A2 in myocardial ischemia and circulatory shock.
Advances in prostaglandin, thromboxane, and leukotriene research 1989;19():321-6.
1988: Stahl G L; Craft D V; Lento P H; Lefer A M
Detection of platelet-activating factor during traumatic shock.
Circulatory shock 1988;26(3):237-44.
1988: Aoki N; Bitterman H; Brezinski M E; Lefer A M
Cardioprotective actions of human superoxide dismutase in two reperfusion models of myocardial ischaemia in the rat.
British journal of pharmacology 1988;95(3):735-40.
1988: Lefer A M; Stahl G L; Lefer D J; Brezinski M E; Nicolaou K C; Veale C A; Abe Y; Smith J B
Lipoxins A4 and B4: comparison of icosanoids having bronchoconstrictor and vasodilator actions but lacking platelet aggregatory activity.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(21):8340-4.
1988: Bitterman H; Smith B A; Lefer A M
Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shock.
Arzneimittel-Forschung 1988;38(10):1389-93.
1988: Lefer A M; Mentley R; Sun J Z
Potentiation of myocardial salvage by tissue type plasminogen activator in combination with a thromboxane synthetase inhibitor in ischemic cat myocardium.
Circulation research 1988;63(3):621-7.
1988: Bitterman H; Smith B A; Lefer D J; Lefer A M
Salutary effects of CG-4203, a novel, stable prostacyclin analog, in hemorrhagic shock.
Journal of cardiovascular pharmacology 1988;12(3):293-9.
1988: Osborne J A; Lefer A M
Cardioprotective actions of thromboxane receptor antagonism in ischemic atherosclerotic rabbits.
The American journal of physiology 1988;255(2 Pt 2):H318-24.
1988: Aoki N; Lefer A M
Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
Methods and findings in experimental and clinical pharmacology 1988;10(7):413-8.
1988: Bitterman H; Aoki N; Lefer A M
Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion (SAO) shock.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1988;188(3):265-71.
1988: Levitt M A; Stahl G; Lefer A M
Efficacy of a combination thromboxane receptor antagonist and lipoxygenase inhibitor in traumatic shock.
Resuscitation 1988;16(3):211-20.
1988: Terashita Z; Stahl G L; Lefer A M
Protective action of prostaglandin E1 (PGE1) against constrictor mediators in isolated rat heart and lung.
Biochemical pharmacology 1988;37(13):2659-65.
1988: Aoki N; Siegfried M; Tsao P; Lento P; Lefer A M
Beneficial mechanisms of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock.
Research communications in chemical pathology and pharmacology 1988;60(3):275-89.
1988: Bitterman H; Lefer D J; Lefer A M
Novel mechanism of action of a prostacyclin enhancing agent in haemorrhagic shock.
Naunyn-Schmiedeberg's archives of pharmacology 1988;337(6):679-86.
1988: Stahl G L; Bitterman H; Terashita Z; Lefer A M
Salutary consequences of blockade of platelet activating factor in hemorrhagic shock.
European journal of pharmacology 1988;149(3):233-40.
1988: Bitterman H; Lefer A M
Use of a novel peptide leukotriene receptor antagonist, Ly-163443, in splanchnic artery occlusion shock.
Prostaglandins, leukotrienes, and essential fatty acids 1988;32(2):63-70.
1988: Bitterman H; Stahl G L; Terashita Z; Lefer A M
Mechanisms of action of PGE1 in hemorrhagic shock in rats.
Annals of emergency medicine 1988;17(5):457-62.
1988: Mentley R K; Brezinski M E; Tse E; Lefer A M
Cardioprotective actions of nisoldipine in postreperfusion myocardial ischemia.
American heart journal 1988;115(5):948-54.
1988: Seltzer J L; Goldberg M E; Larijani G E; Ritter D E; Starsnic M A; Stahl G L; Lefer A M
Prostacyclin mediation of vasodilation following mesenteric traction.
Anesthesiology 1988;68(4):514-8.
1988: Bitterman H; Smith B A; Lefer A M
Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
Circulatory shock 1988;24(3):159-68.
1988: Stahl G L; Terashita Z; Lefer A M
Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia.
The Journal of pharmacology and experimental therapeutics 1988;244(3):898-904.
1988: Bitterman H; Stahl G L; Lefer A M
Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock.
Prostaglandins 1988;35(1):41-50.
1988: Lefer A M
Thromboxane A2 and leukotrienes are eicosanoid mediators of shock and ischemic disorders.
Progress in clinical and biological research 1988;264():101-14.
1988: Terashita Z; Stahl G L; Lefer A M
Protective effects of a platelet activating factor (PAF) antagonist and its combined treatment with prostaglandin (PG) E1 in traumatic shock.
Journal of cardiovascular pharmacology 1988;12(5):505-11.
1988: Lefer D J; Lefer A M
Studies on the mechanism of the vasodilator action of nicorandil.
Life sciences 1988;42(19):1907-14.
1987: Lefer A M; Osborne J A; Yanagisawa A; Sun J Z
Influence of atherosclerosis on vascular responsiveness in isolated rabbit vascular smooth muscle.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1987;1(4):385-91.
1987: Brezinski M E; Osborne J A; Yanagisawa A; Lefer A M
Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia.
Methods and findings in experimental and clinical pharmacology 1987;9(11):703-9.
1987: Stahl G L; Lefer D J; Lefer A M
PAF-acether induced cardiac dysfunction in the isolated perfused guinea pig heart.
Naunyn-Schmiedeberg's archives of pharmacology 1987;336(4):459-63.
1987: Yanagisawa A; Osborne J A; Stahl G L; Lefer A M
Coronary vascular actions of synthetic atrial natriuretic factor in isolated vascular preparations.
Journal of cardiovascular pharmacology 1987;10(3):320-6.
1987: Bitterman H; Lefer D J; Lefer A M
Additive beneficial effects of two inhibitors of vasoconstrictor mediators in acute myocardial ischemia.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1987;185(3):262-6.
1987: Bitterman H; Lefer D J; Lefer A M
Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock.
Methods and findings in experimental and clinical pharmacology 1987;9(6):341-7.
1987: Brezinski M E; Lefer D J; Bowker B; Lefer A M
Thromboxane induced red blood cell lysis.
Prostaglandins 1987;33(1):75-84.
1987: Osborne J A; Mentley R K; Lefer A M
Increased severity of acute myocardial ischemia in experimental atherosclerosis.
Heart and vessels 1987;3(2):73-9.
1987: Darius H; Lefer A M
Pharmacologic antagonism of platelet activating factor and peptide leukotrienes inhibits guinea pig anaphylaxis.
Progress in clinical and biological research 1987;242():303-8.
1987: Lefer A M
Beneficial effects of thromboxane receptor antagonists in acute cardiovascular crises.
Progress in clinical and biological research 1987;242():221-8.
1987: Stahl G L; Lefer A M
Mechanisms of platelet-activating factor-induced cardiac depression in the isolated perfused rat heart.
Circulatory shock 1987;23(3):165-77.
1986: Yanagisawa A; Brezinski M; Lefer A M; Webber S E; Nicolaou K C
Coronary vasoactivity of four 7,13-bridged analogs of arachidonic acid.
Prostaglandins, leukotrienes, and medicine 1986;23(1):15-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Allan Lefer

Research Profile (preview)

Anatomy

Living Beings

Disorders

Chemicals & Drugs

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Allan Lefer (preview)

All Publications